Insider Transactions in Q4 2025 at Ocular Therapeutix, Inc (OCUL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2025
|
Pravin Dugel Director |
BUY
Bona fide gift
|
Indirect |
49,754
+14.22%
|
-
|
|
Nov 26
2025
|
Pravin Dugel Director |
SELL
Bona fide gift
|
Indirect |
49,754
-100.0%
|
-
|
|
Nov 24
2025
|
Jeffrey S. Heier Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,469
-1.39%
|
$41,628
$12.04 P/Share
|
|
Nov 24
2025
|
Peter Kaiser Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,007
-1.55%
|
$36,084
$12.02 P/Share
|
|
Nov 24
2025
|
Pravin Dugel Director |
SELL
Open market or private sale
|
Direct |
19,530
-0.61%
|
$234,360
$12.04 P/Share
|
|
Nov 24
2025
|
Sanjay Nayak Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,878
-0.67%
|
$22,536
$12.04 P/Share
|
|
Nov 05
2025
|
Namrata Saroj Chief Business Officer |
SELL
Open market or private sale
|
Direct |
25,865
-12.93%
|
$258,650
$10.74 P/Share
|
|
Oct 08
2025
|
Todd Anderman Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,132
-11.28%
|
$133,584
$12.34 P/Share
|
|
Oct 02
2025
|
Jeffrey S. Heier Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,502
-4.04%
|
$115,522
$11.04 P/Share
|
|
Oct 02
2025
|
Peter Kaiser Chief Development Officer |
SELL
Open market or private sale
|
Direct |
9,653
-4.73%
|
$106,183
$11.03 P/Share
|